Related Experiment Video
Updated: Mar 15, 2026

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
Tumor Cell Recovery from Senescence Induced by Radiation with PARP Inhibition.
David A Gewirtz1, Moureq Alotaibi1,2, Vasily A Yakovlev3
1Department of a Pharmacology, Toxicology and Medicine and.
PARP inhibitors enhance tumor cell sensitivity to radiation, primarily by increasing senescence, not apoptosis. This senescence may aid immune surveillance but raises concerns about potential tumor recurrence due to cell cycle re-entry.
Area of Science:
- Oncology
- Radiation Oncology
- Molecular Biology
Background:
- Poly(ADP-ribose) polymerase (PARP) inhibitors are approved for BRCA-mutated tumors.
- Expanding PARP inhibitor use to other cancers may involve combination therapies.
- Radiosensitization is a key strategy to enhance cancer treatment efficacy.
Purpose of the Study:
- To investigate the effects of combining PARP inhibitors with ionizing radiation on tumor cells.
- To elucidate the mechanisms of radiosensitization induced by PARP inhibition.
- To assess the long-term implications of PARP inhibition-induced senescence on tumor control.
Main Methods:
- Preclinical studies using experimental animals and cultured tumor cells.
- Assessment of cell behavior, including growth arrest, senescence, and apoptosis, after combined treatment.
- Evaluation of radiosensitization effects and potential for cell cycle recovery.
Main Results:
- PARP inhibition modestly sensitizes most tumor cells to ionizing radiation.
- Radiosensitization is primarily mediated by prolonged growth arrest and senescence, with minimal apoptosis.
- Senescence-induced secretory phenotype may enhance immune surveillance against tumor cells.
Conclusions:
- Combining PARP inhibitors with radiation therapy shows promise for broader tumor treatment.
- Increased senescence is a key mechanism of radiosensitization, potentially aiding tumor control via immune response.
- The potential for senescent cell recovery and cell cycle re-entry warrants further investigation for long-term efficacy and recurrence risk.
More Related Videos
Related Concept Videos
Replicative Cell Senescence
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...

